Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
BIB Stock Summary
Top 10 Correlated ETFs
In the News
Equity CEFs/ETFs: Top Picks For 2024 - Part II
In Part I of my Top Picks For 2024, I explained why we saw such extreme valuation losses in most equity CEFs in 2023 and what that could-mean for 2024. In my opinion, liquidity was the over-riding factor for why so few stocks, think Magnificent 7, received the lion's share of buy-interest while most everything else suffered, including equity CEFs. But just because the Federal Reserve will continue its Quantitative Tapering doesn't mean that other Fed programs won't increase liquidity in other places.
The 7 Best ETFs to Buy to Cover 2023's Biggest Investing Opportunities
These are some of the best ETFs to buy and hold heading into New Year 2023. Rather than being completely tied to the ebb and flow of single-stock ideas, you can gain access to a broad number of similar opportunities at a low price.
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond
Some of the hottest biotech stocks are safe and recession-proof. After all, we can't stop people from aging – at least, not yet.
Why Now Could Be The Time To Consider Neuroscience Investments
Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus to neurological health. Recent advances in genomics and immunology, new diagnostics and surgeries, and reductions in stigma associated with mental health are unlocking radical progress in neuroscience this decade akin to the genomics revolution of the past two decades.
Top Performing Leveraged/Inverse ETFs: 08/07/2022
Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Cap-Weighting Crucial When Indexing Biotech
The biotechnology industry is a bifurcated space. In one corner, you have nascent, small-cap companies that don't yet have steady revenue streams because their new drug or treatment is still in development, hasn't received FDA approval, or hasn't been in the market long enough to establish a proven track record.
How to Invest in Biotech in 2022
It's been a hard year for a lot of the biotech industry, with many hedge funds ending the year with significant losses, but there have been a number of shining stars that are expected to continue to offer investors great performance opportunities. The Wall Street Journal reports that investors who focused on COVID-19 stocks, short [.
Take a Look at the Top-Performing Biotech ETFs YTD
The pandemic has triggered a race to introduce vaccines and treatment options, opening up investment opportunities in the biotech sector.
Tap the Red Hot Biotech Sector With These 2 Leveraged ETFs
Investors could easily tap the bullish trend by considering a near-term long on the biotech sector.
Pfizer-BioNTech COVID-19 Vaccine Garners Full FDA Approval
The FDA has officially given full approval to Pfizer and BioNTech for their COVID-19 vaccine, potentially making way for more approvals and more vaccine mandates, reports CNBC. It is a move that officials are hoping will encourage those who have been reluctant to receive a vaccine to get vaccinated.
BIB Financial details
BIB Financial Performance
BIB Frequently Asked Questions
What is ProShares Ultra Nasdaq Biotechnology stock symbol ?
ProShares Ultra Nasdaq Biotechnology is a US stock and trading under the symbol BIB
What is ProShares Ultra Nasdaq Biotechnology stock quote today ?
ProShares Ultra Nasdaq Biotechnology stock price is $58.14 today.
Is ProShares Ultra Nasdaq Biotechnology stock public?
Yes, ProShares Ultra Nasdaq Biotechnology is a publicly traded company.